Return to collection guide
In the era of personalized medicine, companion diagnostics (CDx) are the key to unlocking the full potential of targeted therapies. At LifeLabs, we offer a comprehensive, end-to-end Companion Diagnostics program that provides seamless support for our pharmaceutical partners. By integrating our deep expertise in genetics and pathology with a robust national infrastructure, we empower you to navigate the complexities of the Canadian healthcare landscape, accelerate patient access to your innovative treatments, and ultimately, improve health.
Our integrated suite of services is designed to provide unwavering support for your targeted therapies, every step of the way.
From clinical development to commercialization, partner with LifeLabs to navigate the Canadian market and accelerate patient access to targeted therapies.
Our Comprehensive Suite of Companion Diagnostics Services
The Lab: Precision, Scale, and Advanced Technology
Our state-of-the-art laboratories are equipped with custom manual and robotic protocols to support projects of any scale. We offer a full suite of services to ensure the highest quality results:
- Nucleic Acid Extraction: Reliable and efficient extraction from a wide variety of sample types.
- Advanced Sequencing & Genotyping: Multiple platforms including PCR, Sanger sequencing, and Next- Generation Sequencing (NGS). Our high-throughput Agena MassARRAY® System is optimized for pharmacogenetic and other SNP-driven applications.
- Integrated Bioinformatics: We provide validated, in-house bioinformatics solutions for sophisticated data analysis, turning complex genomic data into clear, actionable insights.
Provincial Recognition and Quality Assurance
LifeLabs’ designation as a Cancer Care Ontario (CCO) testing site reinforces our position as a trusted, scalable partner for your precision oncology initiatives. This provincial endorsement ensures that your companion diagnostics are delivered within a rigorously validated framework, supporting equitable patient access, consistent clinical quality, and rapid turnaround times across Ontario.
Our CCO designation delivers distinct strategic advantages for your pharmaceutical programs:
- Confidence in Quality: CCO oversight ensures standardized protocols, robust quality management, and validated diagnostic performance across all cases, giving you confidence in every result we deliver.
- Improved Patient Identification: Our centralized, high-volume testing infrastructure enhances your ability to efficiently identify biomarker-positive patients eligible for your innovative therapies.
- Accelerated Clinical Uptake: Working within a recognized provincial pathway reduces operational barriers and drives faster integration of your companion diagnostics into real-world clinical practice.
- Health System Alignment: Our collaboration as a CCO-designated laboratory supports reimbursement strategies, comprehensive data capture, and seamless integration into Ontario’s cancer care delivery model—critical factors for successful commercialization of your targeted treatments.
- Scalable National Blueprint: Our proven success in Canada’s most populous province provides a strong reference model to support your broader Canadian market strategy.
This strategic positioning ensures that you have an implementation-ready partner committed to helping the right patients access the right therapies at the right time.
Genetic Counselling: Supporting the Patient and Provider Journey
A diagnosis that requires a targeted therapy can be a source of confusion and anxiety. Our patient-centric support is designed to bridge this gap:
- Expert Guidance: Our Canadian board-certified, bilingual genetic counsellors guide patients and healthcare providers through the complexities of results interpretation.
- Holistic Assessment: Our counsellors are skilled at incorporating medical and family histories into their assessments, providing a comprehensive and supportive experience that enhances the value of your therapeutic program.
Why Partner with LifeLabs for Companion Diagnostics?
- CCO-Designated Excellence: As a Cancer Care Ontario designated testing site, we deliver companion diagnostics within a provincially endorsed framework that ensures standardized quality, supports reimbursement alignment, and accelerates clinical integration across Ontario’s cancer care ecosystem.
- Extensive Network of Experts: Our established relationships with an extensive network of clinicians including oncologists and pathologists, ensure that healthcare providers trust our processes and the quality of our services.
- Navigate the Canadian Regulatory Landscape: We provide expert guidance to help you navigate Health Canada’s specific regulatory requirements for companion diagnostics, streamlining your path to market access.
- Speed and Efficiency: With rapid turnaround times and optimized workflows, we help accelerate your project timelines and provide the timely results needed for effective therapeutic decision-making.
- End-to-End Customized Solutions: From developing novel assays for emerging biomarkers to providing support for existing companion diagnostics, we offer flexible, tailored solutions to meet the unique requirements of your therapeutic agent.
Transforming Targeted Therapy in Canada
Partnering with LifeLabs for your companion diagnostics needs can significantly impact your success in the Canadian market. We can help you:
- Accelerate Clinical Implementation: Identify the right patient populations for your clinical project, leading to more efficient recruitment and stronger data.
- Optimize Treatment Efficacy: Ensure that your innovative therapies are prescribed to the patients who will benefit most, maximizing therapeutic effectiveness.
- Enhance Market Access: Build the robust evidence you need for a successful submission to Health Canada and subsequent reimbursement negotiations.
- Improve Patient Care: Empower clinicians and improve the lives of patients across Canada by enabling a truly personalized approach to medicine.
Get Started Today
Let’s work together to bring the promise of personalized medicine to more Canadians. Contact us today to learn how our Companion Diagnostics program can support your pharmaceutical solutions and help you achieve your clinical and commercial goals.
For rush results (NAAT within 12 hours and PCR within 24 hours)
- Order your FlyClear test and receive your FlyClear test requisition
- Book an appointment at a LifeLabs location below.
- Bring your printed FlyClear requisition and Passport
- Select your ordered Province’s Rush Test to start booking:
British Columbia6084 Russ Baker Way
Richmond near AirportOntario6084 Russ Baker Way
Richmond near Airport
Pre-Departure testing now available from the comfort of your home with MyVisit (Currently Greater Toronto Area only)
- Order your FlyClear test and receive your FlyClear test requisition.
- Book your Home Visit appointment with the MyVisit portal or, if your flight is within the next five days, contact a MyVisit coordinator 1-416-993-9579 (Monday – Friday, 9am-5pm EST)
MyVisit Pre-departure testing offers:
- COVID-19 PCR/NAAT swab testing
- COVID-19 Antibody Blood (serology) testing
The MyVisit fee is $80 per person.
Pre-Departure testing
Book your appointment online here. If your flight is within the next five days and you have received your FlyClear requisition, please contact a MyVisit coordinator 1-416-993-9579 (Monday – Friday, 9am-5pm EST).